Q2 2025

Filed Aug 13, 2025 · 10-Q · 44 days after period end · 0001140361-25-030836

Q2 2025 · 10-Q

Revenue

$2.88M

+159.2% vs Q2 2024

Net Income

-$7.42M

N/M vs Q2 2024

EPS Diluted

-$0.12

N/M vs Q2 2024

Operating Income-$8,906,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2025	Q2 2024	Q2 2023	Q2 2022
Revenue	$2.88M	$1.11M	$3.67M	$0.00
Net Income	-$7.42M	-$7.77M	-$4.96M	-$4.93M
EPS Diluted	-$0.12	-$0.30	-$0.24	-$0.25

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR